Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Metabolic syndrome identified as risk factor for kidney-pancreas transplant patients

23.01.2006


A three-year multi-center study of kidney-pancreas transplant recipients has identified a new risk factor for impaired kidney function, which may help physicians refine their treatment strategies.



Researchers from Wake Forest University Baptist Medical Center and colleagues reported their findings today at the 6th Annual American Society of Transplant Surgeons State of the Art Winter Symposium in Scottsdale, Ariz.

The researchers found that metabolic syndrome, a cluster of symptoms that increase the risk of heart disease, is also a risk factor for deterioration of kidney function in simultaneous kidney-pancreas transplant recipients. The risk is especially high when the pancreas transplant fails. The study involved 298 patients at 25 transplant centers.


"The findings suggest that we need to do whatever we can to keep the transplanted pancreas functioning because it may protect against development of long-term kidney transplant dysfunction," said Jeffrey Rogers, M.D., a Wake Forest transplant surgeon. "The findings also underscore the importance of controlling weight, blood pressure, blood sugar and cholesterol – the variables that define metabolic syndrome."

In kidney and pancreas transplantation, advances in immunosuppressive drug therapy have significantly reduced the risk of acute rejection. Transplant surgeons are now increasingly focused on developing strategies to prevent or slow a gradual deterioration in kidney function that can lead to the need for a second transplant.

Previous research had shown that metabolic syndrome is a risk factor for chronic deterioration of kidney function in kidney transplant recipients. However, the effect of metabolic syndrome on the outcome of simultaneous kidney-pancreas transplantation and the significance of having a functioning pancreas transplant in these patients has not been previously described.

About 700 kidney-pancreas transplants are performed each year in the United States. The procedure is performed in patients who have either type 1 or type 2 diabetes and kidney failure. The pancreas produces insulin, a hormone that helps regulate levels of blood sugar. People with diabetes do not produce enough insulin or cannot use insulin effectively. The primary function of the kidneys is to filter waste products and extra water from the body by producing urine.

Metabolic syndrome is diagnosed when someone has at least three of these following: body mass index greater than 30 or waist size larger than 40 inches for men or 35 inches for women, high levels of triglycerides, low levels of "good" cholesterol, high blood pressure or high levels of blood sugar.

The study followed 298 patients for three years after simultaneous kidney-pancreas transplantation. The researchers found that the prevalence of metabolic syndrome decreased from 59 percent prior to transplant to 19 percent one year after transplant. This would be expected because the transplant would eliminate diabetes – one of the components of metabolic syndrome.

Patients who had metabolic syndrome one year after transplant were 10 times more likely to have reduced kidney function three years after transplant than patients who did not have metabolic syndrome. The researchers analyzed how function of the transplanted pancreas affected the relationship between metabolic syndrome and kidney function and found that patients with metabolic syndrome who developed early pancreas transplant failure had the highest risk of developing long-term kidney dysfunction.

Rogers said that further study was needed to better understand the role a functioning pancreas transplant plays in preserving kidney transplant function in patients with metabolic syndrome so that long-term survival of both organs can continue to be improved.

Karen Richardson | EurekAlert!
Further information:
http://www.wfubmc.edu

More articles from Health and Medicine:

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

nachricht The gut microbiota plays a key role in treatment with classic diabetes medication
01.06.2017 | University of Gothenburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Quantum thermometer or optical refrigerator?

23.06.2017 | Physics and Astronomy

A 100-year-old physics problem has been solved at EPFL

23.06.2017 | Physics and Astronomy

Equipping form with function

23.06.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>